Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Xtandi
Xtandi
Medivation Destined To Become A Biotech Behemoth As Low-Risk Pipeline Expands
Seeking Alpha
Wed, 09/2/15 - 12:43 pm
talazoparib
Medivation
Xtandi
pidilizumab
Patent Claims To Xtandi Seem Weak
Seeking Alpha
Tue, 08/11/15 - 11:20 am
patents
Xtandi
Chugai
Roche
Why Shares in Medivation Inc. Tumbled Over 10% in June
Motley Fool
Sun, 07/12/15 - 09:34 am
Medivation
Xtandi
prostate cancer
Astellas, Medivation to amp up unbranded Xtandi marketing for pre-chemo use
Fierce Pharma Marketing
Wed, 06/17/15 - 10:24 am
Astellas
Medivation
Xtandi
drug marketing
prostate cancer
Medivation's Xtandi sales fell short in Q1, but analysts say it's gaining on J&J's Zytiga
Fierce Pharma Marketing
Wed, 05/20/15 - 06:15 pm
Medivation
Xtandi
Astellas
JNJ
Zytiga
Chugai Pharma Appears To Own U.S., Japan And EU Patent Rights To Medivation's Xtandi
Seeking Alpha
Tue, 05/12/15 - 04:29 pm
Chugai
Medivation
Xtandi
patents
Japan
Europe
Medivation's Xtandi Beats Casodex In Cancer Trial
Investors.com
Fri, 04/3/15 - 08:38 am
Medivation
Xtandi
Casodex
Astellas
prostate cancer
Will Medivation Kick J&J To The Curb For This $9 Billion Market?
Seeking Alpha
Wed, 03/4/15 - 09:46 am
JNJ
Medivation
Xtandi
Medivation Poised To Expand As Xtandi Shows Efficacy In Advanced Triple Negative Breast Cancer
Seeking Alpha
Wed, 12/17/14 - 08:53 am
Medivation
Xtandi
triple negative breast cancer
breast cancer
Should Johnson & Johnson Buy Medivation Inc.?
Motley Fool
Wed, 11/12/14 - 08:41 am
JNJ
Medivation
M&A
Xtandi
prostate cancer
Sovaldi's not the only superhero launch: Meet the rest of the pharma Avengers
Fierce Pharma Marketing
Thu, 11/6/14 - 09:03 am
Sovaldi
Gilead Sciences
Eyelea
Tecfidera
Zytiga
Kalydeco
Vertex Pharmaceuticals
Victoza
Novo Nordisk
Gilenya
Yervoy
Xtandi
Stribild
Stelara
Strong Prostate Cancer Drug Sales Will Help Medivation Expand Pipeline
TheStreet.com
Wed, 11/5/14 - 08:07 am
prostate cancer
Medivation
Xtandi
J&J Likely To Report Drop In Zytiga Sales On Xtandi‘s Entry In Prostate Cancer Market
Bidness Etc.
Mon, 09/22/14 - 09:56 am
Zytiga
Xtandi
JNJ
prostate cancer
Medivation
Astellas
Xtandi field force to increase by 50% for market-share battle with Zytiga
Fierce Pharma Marketing
Mon, 09/15/14 - 07:30 pm
Xtandi
Medivation
Astellas
hirings
JNJ
Zytiga
U.S. FDA okays expanded use of Medivation prostate cancer drug
Yahoo/Reuters
Wed, 09/10/14 - 08:35 pm
Medivation
FDA
prostate cancer
Xtandi
Is This Johnson & Johnson's Worst Nightmare?
Motley Fool
Tue, 07/8/14 - 04:07 pm
JNJ
Zytiga
Medivation
Xtandi
Olysio
Gilead Sciences
Sovaldi
New England Journal of Medicine Publishes Results From Phase 3 PREVAIL Trial Of Enzalutamide In Men With Chemotherapy-Naïve Metastatic Prostate Cancer
Yahoo/BusinessWire
Sun, 06/1/14 - 11:40 am
Enzalutamide
prostate cancer
metastatic prostate cancer
Xtandi
Astellas
Companies Betting on the Next 10 Blockbuster Drugs
24/7WallStreet
Wed, 04/23/14 - 11:57 am
Juxtapid
Otezla
Aegerion
Celgene
GW Pharma
Sativex
Intercept Pharma
OCA
Ironwood Pharmaceuticals
Linzess
Lpath
iSONEP
MannKind
Afrezza
Xtandi
H.P. Acthar Gel
Questcor Pharmaceuticals
eteplirsen
Sarepta Therapeutics
Biotech Stock Roundup: Strong Show from Biogen & Alexion; Medivation PREVAILs
Yahoo/Zacks.com
Wed, 02/5/14 - 09:40 am
Biogen Idec
Alexion
Medivation
Xtandi
This Week in Biotech: Let's Get Clinical!
Motley Fool
Sun, 02/2/14 - 11:30 am
AbbVie
Enanta Pharmaceuticals
ABT-450
hepatitis C
Medivation
Xtandi
prostate cancer
Astellas
Geron
imetelstat
PSMA-ADC
Progenics Pharmaceuticals
Idenix
Pages
« first
‹ previous
1
2
3
4
5
6
next ›
last »